Showing 11,821 - 11,840 results of 60,794 for search '(( 50 ((ns decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (nn decrease)) ))', query time: 1.02s Refine Results
  1. 11821

    Table 7_Comparative genomics and metabolomics reveal phytohormone production, nutrient acquisition, and osmotic stress tolerance in Azotobacter chroococcum W5.xlsx by M. Elakkya (21760439)

    Published 2025
    “…The use of plant growth-promoting bacteria (PGPB) offers a promising alternative to enhance soil quality and crop yield while reducing the consumption of chemical fertilizers.</p>Methods<p>Here, we characterize the plant growth-promoting potential of Azotobacter chroococcum W5 through comparative genomics, in vitro experiments, and metabolomic analyses.…”
  2. 11822

    Data_Sheet_1_ClpV3 of the H3-Type VI Secretion System (H3-T6SS) Affects Multiple Virulence Factors in Pseudomonas aeruginosa.docx by Yanqi Li (3395705)

    Published 2020
    “…We also observed that the intracellular concentration of secondary messenger cAMP was reduced in PAO1(ΔclpV3), and the c-di-GMP level was also decreased as indicated by the decreased cdrA reporter activity. …”
  3. 11823
  4. 11824

    DataSheet_5_Salivary and Intestinal Transcriptomes Reveal Differential Gene Expression in Starving, Fed and Trypanosoma cruzi-Infected Rhodnius neglectus.zip by Tamires Marielem Carvalho-Costa (11858396)

    Published 2021
    “…We also found decreased transcriptional expression of lipocalins and nitrophorins in SG and two new proteins, pacifastin and diptericin, in INT. …”
  5. 11825

    DataSheet2_Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine.zip by Piao-Piao Huang (9930141)

    Published 2022
    “…Besides, female C57BL/6J mice were treated with olanzapine (3 mg/kg/day versus 6 mg/kg/day) for 6 weeks. We demonstrated that short-term use of olanzapine increased plasma triglyceride and decreased plasma apoA5 levels in the patients and mice, with a negative correlation between the two factors. …”
  6. 11826

    DataSheet1_Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine.pdf by Piao-Piao Huang (9930141)

    Published 2022
    “…Besides, female C57BL/6J mice were treated with olanzapine (3 mg/kg/day versus 6 mg/kg/day) for 6 weeks. We demonstrated that short-term use of olanzapine increased plasma triglyceride and decreased plasma apoA5 levels in the patients and mice, with a negative correlation between the two factors. …”
  7. 11827
  8. 11828

    Table_5_The effects of elemene emulsion injection on rat fecal microbiota and metabolites: Evidence from metagenomic exploration and liquid chromatography-mass spectrometry.pdf by Lei Gu (422613)

    Published 2022
    “…In contrast, L-EEI significantly increased Ruminococcus bromii and Dorea sp. 5–2 abundance, and Oscillibacter sp. 1–3 abundance tended to increase, while H-EEI significantly decreased them. (3) L-EEI and H-EEI decreased the abundance of bacteria (Ruminococcaceae bacterium, Romboutsia ilealis, and Staphylococcus xylosus). …”
  9. 11829

    Image_5_The effects of elemene emulsion injection on rat fecal microbiota and metabolites: Evidence from metagenomic exploration and liquid chromatography-mass spectrometry.pdf by Lei Gu (422613)

    Published 2022
    “…In contrast, L-EEI significantly increased Ruminococcus bromii and Dorea sp. 5–2 abundance, and Oscillibacter sp. 1–3 abundance tended to increase, while H-EEI significantly decreased them. (3) L-EEI and H-EEI decreased the abundance of bacteria (Ruminococcaceae bacterium, Romboutsia ilealis, and Staphylococcus xylosus). …”
  10. 11830

    Integrative Proteomic and Cytological Analysis of the Effects of Extracellular Ca<sup>2+</sup> Influx on <i>Pinus bungeana</i> Pollen Tube Development by Xiaoqin Wu (470428)

    Published 2008
    “…Blocking the L-type Ca<sup>2+</sup> channel with Nif in the pollen tube membrane induced several early alterations within a short time, including a reduction of extracellular Ca<sup>2+</sup> influx and a subsequently dramatic decrease in cytosolic free Ca<sup>2+</sup> concentration ([Ca<sup>2+</sup>]<sub>c</sub>), concomitant with ultrastructural abnormalities and changes in the abundance of proteins involved in energy production and signaling. …”
  11. 11831
  12. 11832
  13. 11833

    Table_5_RNA 2’-O-Methyltransferase Fibrillarin Facilitates Virus Entry Into Macrophages Through Inhibiting Type I Interferon Response.xlsx by Panpan Li (484033)

    Published 2022
    “…Once FBL is down-regulated, the decreased Nm modifications of RNA in macrophages may act as “non-self” RNA and be recognized by RNA sensor interferon induced with helicase C domain 1 (MDA5), leading to innate immune activation by inducing the expression of IFN-I and ISGs. …”
  14. 11834

    Image_5_A Novel Chloroplast Protein RNA Processing 8 Is Required for the Expression of Chloroplast Genes and Chloroplast Development in Arabidopsis thaliana.TIF by Mengmeng Kong (11815760)

    Published 2021
    “…The abundance of the chloroplast rRNA, including 23S, 16S, 4.5S, and 5S rRNA, were reduced in the rp8 mutant, respectively, and the amounts of chloroplast ribosome proteins, such as, PRPS1(uS1c), PRPS5(uS5c), PRPL2 (uL2c), and PRPL4 (uL4c), were substantially decreased in the rp8 mutant, which indicated that knockout of RP8 seriously affected chloroplast translational machinery. …”
  15. 11835

    Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic Disorders by Pinaki Bhattacharjee (11971366)

    Published 2025
    “…CB<sub>1</sub> receptor antagonists that are peripherally acting hold promise for treating obesity, diabetes and fibrotic disorders highlighting their importance in treating metabolic syndrome disorders (MetS). We synthesized and evaluated compounds by integrating amidine fragments into 1,4,5,6-tetrahydropyridazine-based sulfonyl urea scaffolds for blocking CB<sub>1</sub> receptors. …”
  16. 11836

    Table_1_EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.DOCX by Hongda Pan (6996182)

    Published 2019
    “…In this study, we investigated the functions and mechanisms by which EXOSC5 promotes the progression of CRC.…”
  17. 11837

    Image_5_Identification, Characterization, and Transcriptional Reprogramming of Epithelial Stem Cells and Intestinal Enteroids in Simian Immunodeficiency Virus Infected Rhesus Macaq... by Nongthombam Boby (4255957)

    Published 2021
    “…Understanding the molecular mechanisms underlying the disrupted epithelial regeneration might provide an alternative approach for the treatment of HIV-mediated enteropathy and immune activation. We have observed a significant increased presence of α defensin5+ (HD5) Paneth cells and proliferating Ki67+ epithelial cells as well as decreased expression of E-cadherin expression in epithelial cells during SIV infection. …”
  18. 11838

    Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic Disorders by Pinaki Bhattacharjee (11971366)

    Published 2025
    “…CB<sub>1</sub> receptor antagonists that are peripherally acting hold promise for treating obesity, diabetes and fibrotic disorders highlighting their importance in treating metabolic syndrome disorders (MetS). We synthesized and evaluated compounds by integrating amidine fragments into 1,4,5,6-tetrahydropyridazine-based sulfonyl urea scaffolds for blocking CB<sub>1</sub> receptors. …”
  19. 11839

    Table_1_EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.DOCX by Hongda Pan (6996182)

    Published 2021
    “…In this study, we investigated the functions and mechanisms by which EXOSC5 promotes the progression of CRC.…”
  20. 11840

    Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic Disorders by Pinaki Bhattacharjee (11971366)

    Published 2025
    “…CB<sub>1</sub> receptor antagonists that are peripherally acting hold promise for treating obesity, diabetes and fibrotic disorders highlighting their importance in treating metabolic syndrome disorders (MetS). We synthesized and evaluated compounds by integrating amidine fragments into 1,4,5,6-tetrahydropyridazine-based sulfonyl urea scaffolds for blocking CB<sub>1</sub> receptors. …”